nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentamidine—TRDMT1—cardiovascular system—nicotine dependence	0.0609	0.498	CbGeAlD
Pentamidine—Pleurisy—Varenicline—nicotine dependence	0.0455	0.0702	CcSEcCtD
Pentamidine—Splenomegaly—Varenicline—nicotine dependence	0.04	0.0617	CcSEcCtD
Pentamidine—Respiratory tract congestion—Varenicline—nicotine dependence	0.0305	0.047	CcSEcCtD
Pentamidine—Haematochezia—Varenicline—nicotine dependence	0.0276	0.0426	CcSEcCtD
Pentamidine—CYP4A11—Fatty acids—CYP2A7—nicotine dependence	0.0254	0.111	CbGpPWpGaD
Pentamidine—Pancreatitis acute—Varenicline—nicotine dependence	0.0241	0.0371	CcSEcCtD
Pentamidine—S100B—cardiovascular system—nicotine dependence	0.0239	0.196	CbGeAlD
Pentamidine—Night sweats—Varenicline—nicotine dependence	0.0206	0.0318	CcSEcCtD
Pentamidine—Gastric ulcer—Varenicline—nicotine dependence	0.0191	0.0295	CcSEcCtD
Pentamidine—S100B—midbrain—nicotine dependence	0.0187	0.153	CbGeAlD
Pentamidine—Paranoia—Varenicline—nicotine dependence	0.0163	0.0251	CcSEcCtD
Pentamidine—Gingivitis—Varenicline—nicotine dependence	0.0142	0.0218	CcSEcCtD
Pentamidine—Chest discomfort—Varenicline—nicotine dependence	0.0126	0.0194	CcSEcCtD
Pentamidine—CYP2C8—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0118	0.0517	CbGpPWpGaD
Pentamidine—S100B—brain—nicotine dependence	0.0117	0.096	CbGeAlD
Pentamidine—Hyperkalaemia—Varenicline—nicotine dependence	0.0109	0.0168	CcSEcCtD
Pentamidine—Salivary hypersecretion—Varenicline—nicotine dependence	0.0108	0.0166	CcSEcCtD
Pentamidine—CYP2C19—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0106	0.0462	CbGpPWpGaD
Pentamidine—Mouth ulceration—Varenicline—nicotine dependence	0.01	0.0155	CcSEcCtD
Pentamidine—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00973	0.0425	CbGpPWpGaD
Pentamidine—Diabetes mellitus—Varenicline—nicotine dependence	0.00928	0.0143	CcSEcCtD
Pentamidine—Eye pain—Varenicline—nicotine dependence	0.00894	0.0138	CcSEcCtD
Pentamidine—Renal failure acute—Varenicline—nicotine dependence	0.00874	0.0135	CcSEcCtD
Pentamidine—Amnesia—Varenicline—nicotine dependence	0.00859	0.0132	CcSEcCtD
Pentamidine—CYP3A5—Xenobiotics—CYP2A7—nicotine dependence	0.00848	0.037	CbGpPWpGaD
Pentamidine—CYP4A11—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00838	0.0366	CbGpPWpGaD
Pentamidine—CYP4A11—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00827	0.0361	CbGpPWpGaD
Pentamidine—Hypoglycaemia—Varenicline—nicotine dependence	0.00827	0.0127	CcSEcCtD
Pentamidine—Cerebrovascular accident—Varenicline—nicotine dependence	0.00823	0.0127	CcSEcCtD
Pentamidine—Lethargy—Varenicline—nicotine dependence	0.00823	0.0127	CcSEcCtD
Pentamidine—CYP1A1—Xenobiotics—CYP2A7—nicotine dependence	0.00801	0.035	CbGpPWpGaD
Pentamidine—Affect lability—Varenicline—nicotine dependence	0.00794	0.0122	CcSEcCtD
Pentamidine—Psychotic disorder—Varenicline—nicotine dependence	0.00788	0.0122	CcSEcCtD
Pentamidine—Mood swings—Varenicline—nicotine dependence	0.00764	0.0118	CcSEcCtD
Pentamidine—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00759	0.0331	CbGpPWpGaD
Pentamidine—Liver function test abnormal—Varenicline—nicotine dependence	0.00745	0.0115	CcSEcCtD
Pentamidine—Dry skin—Varenicline—nicotine dependence	0.0074	0.0114	CcSEcCtD
Pentamidine—CYP2C8—Xenobiotics—CYP2A7—nicotine dependence	0.00735	0.0321	CbGpPWpGaD
Pentamidine—Gastritis—Varenicline—nicotine dependence	0.00714	0.011	CcSEcCtD
Pentamidine—Asthma—Varenicline—nicotine dependence	0.00697	0.0108	CcSEcCtD
Pentamidine—CYP4A11—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.0068	0.0297	CbGpPWpGaD
Pentamidine—Bronchitis—Varenicline—nicotine dependence	0.00671	0.0103	CcSEcCtD
Pentamidine—CYP2C19—Xenobiotics—CYP2A7—nicotine dependence	0.00656	0.0286	CbGpPWpGaD
Pentamidine—Hyperglycaemia—Varenicline—nicotine dependence	0.00629	0.0097	CcSEcCtD
Pentamidine—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.00616	0.0095	CcSEcCtD
Pentamidine—Stomatitis—Varenicline—nicotine dependence	0.00606	0.00935	CcSEcCtD
Pentamidine—Conjunctivitis—Varenicline—nicotine dependence	0.00604	0.00932	CcSEcCtD
Pentamidine—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.00603	0.0263	CbGpPWpGaD
Pentamidine—Sinusitis—Varenicline—nicotine dependence	0.00583	0.00899	CcSEcCtD
Pentamidine—Bradycardia—Varenicline—nicotine dependence	0.00568	0.00876	CcSEcCtD
Pentamidine—Hallucination—Varenicline—nicotine dependence	0.00555	0.00856	CcSEcCtD
Pentamidine—Hypoaesthesia—Varenicline—nicotine dependence	0.00555	0.00856	CcSEcCtD
Pentamidine—Oedema peripheral—Varenicline—nicotine dependence	0.0055	0.00848	CcSEcCtD
Pentamidine—Erythema multiforme—Varenicline—nicotine dependence	0.00528	0.00814	CcSEcCtD
Pentamidine—CYP1A2—Xenobiotics—CYP2A7—nicotine dependence	0.00511	0.0223	CbGpPWpGaD
Pentamidine—Chills—Varenicline—nicotine dependence	0.00501	0.00772	CcSEcCtD
Pentamidine—Arrhythmia—Varenicline—nicotine dependence	0.00499	0.00769	CcSEcCtD
Pentamidine—Erythema—Varenicline—nicotine dependence	0.00486	0.00749	CcSEcCtD
Pentamidine—Dysgeusia—Varenicline—nicotine dependence	0.00476	0.00734	CcSEcCtD
Pentamidine—Vision blurred—Varenicline—nicotine dependence	0.00458	0.00706	CcSEcCtD
Pentamidine—Tremor—Varenicline—nicotine dependence	0.00455	0.00702	CcSEcCtD
Pentamidine—Anaemia—Varenicline—nicotine dependence	0.00449	0.00692	CcSEcCtD
Pentamidine—Angioedema—Varenicline—nicotine dependence	0.00444	0.00685	CcSEcCtD
Pentamidine—Vertigo—Varenicline—nicotine dependence	0.00437	0.00673	CcSEcCtD
Pentamidine—Syncope—Varenicline—nicotine dependence	0.00436	0.00672	CcSEcCtD
Pentamidine—Palpitations—Varenicline—nicotine dependence	0.00429	0.00662	CcSEcCtD
Pentamidine—Loss of consciousness—Varenicline—nicotine dependence	0.00427	0.00658	CcSEcCtD
Pentamidine—Cough—Varenicline—nicotine dependence	0.00424	0.00654	CcSEcCtD
Pentamidine—Convulsion—Varenicline—nicotine dependence	0.00421	0.00649	CcSEcCtD
Pentamidine—Hypertension—Varenicline—nicotine dependence	0.00419	0.00647	CcSEcCtD
Pentamidine—Chest pain—Varenicline—nicotine dependence	0.00414	0.00638	CcSEcCtD
Pentamidine—Arthralgia—Varenicline—nicotine dependence	0.00414	0.00638	CcSEcCtD
Pentamidine—Myalgia—Varenicline—nicotine dependence	0.00414	0.00638	CcSEcCtD
Pentamidine—Anxiety—Varenicline—nicotine dependence	0.00412	0.00636	CcSEcCtD
Pentamidine—Discomfort—Varenicline—nicotine dependence	0.00409	0.0063	CcSEcCtD
Pentamidine—Dry mouth—Varenicline—nicotine dependence	0.00405	0.00624	CcSEcCtD
Pentamidine—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00394	0.0172	CbGpPWpGaD
Pentamidine—Infection—Varenicline—nicotine dependence	0.00394	0.00607	CcSEcCtD
Pentamidine—Shock—Varenicline—nicotine dependence	0.0039	0.00602	CcSEcCtD
Pentamidine—Thrombocytopenia—Varenicline—nicotine dependence	0.00388	0.00599	CcSEcCtD
Pentamidine—Tachycardia—Varenicline—nicotine dependence	0.00387	0.00597	CcSEcCtD
Pentamidine—Anorexia—Varenicline—nicotine dependence	0.00378	0.00583	CcSEcCtD
Pentamidine—Hypotension—Varenicline—nicotine dependence	0.00371	0.00571	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00361	0.00557	CcSEcCtD
Pentamidine—CYP4A11—Biological oxidations—CYP2A7—nicotine dependence	0.00361	0.0158	CbGpPWpGaD
Pentamidine—Insomnia—Varenicline—nicotine dependence	0.00359	0.00553	CcSEcCtD
Pentamidine—Dyspnoea—Varenicline—nicotine dependence	0.00354	0.00545	CcSEcCtD
Pentamidine—Somnolence—Varenicline—nicotine dependence	0.00353	0.00544	CcSEcCtD
Pentamidine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00352	0.0154	CbGpPWpGaD
Pentamidine—Dyspepsia—Varenicline—nicotine dependence	0.00349	0.00538	CcSEcCtD
Pentamidine—CYP3A5—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00348	0.0152	CbGpPWpGaD
Pentamidine—Decreased appetite—Varenicline—nicotine dependence	0.00345	0.00532	CcSEcCtD
Pentamidine—Fatigue—Varenicline—nicotine dependence	0.00342	0.00527	CcSEcCtD
Pentamidine—Constipation—Varenicline—nicotine dependence	0.00339	0.00523	CcSEcCtD
Pentamidine—Pain—Varenicline—nicotine dependence	0.00339	0.00523	CcSEcCtD
Pentamidine—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00333	0.0145	CbGpPWpGaD
Pentamidine—CYP1A1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00328	0.0143	CbGpPWpGaD
Pentamidine—Feeling abnormal—Varenicline—nicotine dependence	0.00327	0.00504	CcSEcCtD
Pentamidine—Gastrointestinal pain—Varenicline—nicotine dependence	0.00324	0.005	CcSEcCtD
Pentamidine—Urticaria—Varenicline—nicotine dependence	0.00315	0.00486	CcSEcCtD
Pentamidine—Abdominal pain—Varenicline—nicotine dependence	0.00313	0.00483	CcSEcCtD
Pentamidine—Body temperature increased—Varenicline—nicotine dependence	0.00313	0.00483	CcSEcCtD
Pentamidine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00305	0.0133	CbGpPWpGaD
Pentamidine—CYP2C8—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00301	0.0131	CbGpPWpGaD
Pentamidine—Hypersensitivity—Varenicline—nicotine dependence	0.00292	0.0045	CcSEcCtD
Pentamidine—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00285	0.0125	CbGpPWpGaD
Pentamidine—Asthenia—Varenicline—nicotine dependence	0.00284	0.00439	CcSEcCtD
Pentamidine—Pruritus—Varenicline—nicotine dependence	0.00281	0.00433	CcSEcCtD
Pentamidine—CYP2C8—brain—nicotine dependence	0.00275	0.0225	CbGeAlD
Pentamidine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00272	0.0119	CbGpPWpGaD
Pentamidine—Diarrhoea—Varenicline—nicotine dependence	0.00271	0.00418	CcSEcCtD
Pentamidine—CYP1A1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.0027	0.0118	CbGpPWpGaD
Pentamidine—CYP2C19—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00269	0.0117	CbGpPWpGaD
Pentamidine—Dizziness—Varenicline—nicotine dependence	0.00262	0.00404	CcSEcCtD
Pentamidine—CYP1A1—brain—nicotine dependence	0.00254	0.0207	CbGeAlD
Pentamidine—Vomiting—Varenicline—nicotine dependence	0.00252	0.00389	CcSEcCtD
Pentamidine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0025	0.0109	CbGpPWpGaD
Pentamidine—Rash—Varenicline—nicotine dependence	0.0025	0.00386	CcSEcCtD
Pentamidine—Dermatitis—Varenicline—nicotine dependence	0.0025	0.00385	CcSEcCtD
Pentamidine—Headache—Varenicline—nicotine dependence	0.00248	0.00383	CcSEcCtD
Pentamidine—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00247	0.0108	CbGpPWpGaD
Pentamidine—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00247	0.0108	CbGpPWpGaD
Pentamidine—Nausea—Varenicline—nicotine dependence	0.00236	0.00363	CcSEcCtD
Pentamidine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00221	0.00963	CbGpPWpGaD
Pentamidine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00212	0.00926	CbGpPWpGaD
Pentamidine—CYP1A2—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00209	0.00914	CbGpPWpGaD
Pentamidine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00203	0.00886	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—WASF2—nicotine dependence	0.00187	0.00816	CbGpPWpGaD
Pentamidine—CYP2D6—brain—nicotine dependence	0.00183	0.015	CbGeAlD
Pentamidine—S100B—Innate Immune System—WASF1—nicotine dependence	0.00179	0.00783	CbGpPWpGaD
Pentamidine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00172	0.00751	CbGpPWpGaD
Pentamidine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00164	0.00715	CbGpPWpGaD
Pentamidine—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00162	0.00705	CbGpPWpGaD
Pentamidine—CYP3A5—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00161	0.00702	CbGpPWpGaD
Pentamidine—CYP1A1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00152	0.00663	CbGpPWpGaD
Pentamidine—CYP3A5—Biological oxidations—CYP2A7—nicotine dependence	0.00152	0.00662	CbGpPWpGaD
Pentamidine—CYP3A5—Metapathway biotransformation—CYP2A7—nicotine dependence	0.0015	0.00653	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—TAS2R16—nicotine dependence	0.00144	0.00629	CbGpPWpGaD
Pentamidine—CYP1A1—Biological oxidations—CYP2A7—nicotine dependence	0.00143	0.00625	CbGpPWpGaD
Pentamidine—CYP1A1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00141	0.00617	CbGpPWpGaD
Pentamidine—CYP2C8—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00139	0.00608	CbGpPWpGaD
Pentamidine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00133	0.00579	CbGpPWpGaD
Pentamidine—CYP2C8—Biological oxidations—CYP2A7—nicotine dependence	0.00131	0.00573	CbGpPWpGaD
Pentamidine—CYP2C8—Metapathway biotransformation—CYP2A7—nicotine dependence	0.0013	0.00565	CbGpPWpGaD
Pentamidine—CYP2C19—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00124	0.00543	CbGpPWpGaD
Pentamidine—CYP2C19—Biological oxidations—CYP2A7—nicotine dependence	0.00117	0.00512	CbGpPWpGaD
Pentamidine—CYP2C19—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00116	0.00505	CbGpPWpGaD
Pentamidine—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00114	0.00499	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—FGD1—nicotine dependence	0.00113	0.00494	CbGpPWpGaD
Pentamidine—S100B—Immune System—WASF2—nicotine dependence	0.00109	0.00475	CbGpPWpGaD
Pentamidine—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.00108	0.00471	CbGpPWpGaD
Pentamidine—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00106	0.00464	CbGpPWpGaD
Pentamidine—S100B—Immune System—WASF1—nicotine dependence	0.00104	0.00456	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—AKR1B10—nicotine dependence	0.001	0.00436	CbGpPWpGaD
Pentamidine—CYP1A2—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000969	0.00423	CbGpPWpGaD
Pentamidine—CYP1A2—Biological oxidations—CYP2A7—nicotine dependence	0.000913	0.00399	CbGpPWpGaD
Pentamidine—CYP1A2—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000901	0.00393	CbGpPWpGaD
Pentamidine—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000748	0.00326	CbGpPWpGaD
Pentamidine—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000705	0.00308	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—WASF2—nicotine dependence	0.000704	0.00307	CbGpPWpGaD
Pentamidine—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000695	0.00303	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—WASF1—nicotine dependence	0.000675	0.00295	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—CYP2A7—nicotine dependence	0.000617	0.00269	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—OPRM1—nicotine dependence	0.000608	0.00265	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—DRD2—nicotine dependence	0.00044	0.00192	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CYP2A7—nicotine dependence	0.000259	0.00113	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CYP2A7—nicotine dependence	0.000245	0.00107	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CYP2A7—nicotine dependence	0.000225	0.00098	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CYP2A7—nicotine dependence	0.0002	0.000875	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CYP2A7—nicotine dependence	0.000184	0.000805	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CYP2A7—nicotine dependence	0.000156	0.000682	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CYP2A7—nicotine dependence	0.000121	0.000526	CbGpPWpGaD
